A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/415 (2006.01) A61K 41/00 (2006.01) A61K 45/06 (2006.01) A61K 47/48 (2006.01) A61K 51/04 (2006.01) C07D 401/14 (2006.01) C07D 403/06 (2006.01) C07D 403/14 (2006.01) C07F 9/6503 (2006.01) C07F 9/6524 (2006.01) C07F 9/6558 (2006.01) C07F 13/00 (2006.01) C07K 5/02 (2006.01) C07K 5/06 (2006.01) C07K 9/00 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2413957
The present invention describes novel kits and compositions comprising compounds of the formula (I):(Q)d-Ln-Ch, useful for the diagnosis and treatment of cancer in combination therapy in a patient. The present invention provides novel compounds useful for the treatment of rheumatoid arthritis. The pharmaceuticals are comprised of a targeting moiety that binds to a receptor that is upregulated during angiogenesis, an optional linking group, and a therapeutically effective radioisotope or diagnostically effective imageable moiety.
L'invention concerne de nouveaux ensembles et des compositions comprenant des composants de formule (I):(Q)¿d?-L¿n?-C¿h?, (I) servant à diagnostiquer et à traiter le cancer en polythérapie chez un patient. L'invention concerne également de nouveaux composants utilisés afin de traiter l'arthrite rhumatoïde. Les produits pharmaceutiques sont composés d'un groupe fonctionnel de ciblage qui se lie à un récepteur qui est régulé en amont pendant l'angiogénese, un groupe de liaison facultatif et un radio-isotope thérapeutiquement efficace ou un groupe fonctionnel imageable diagnostiquement efficace.
Barrett John A.
Carpenter Alan P. Jr.
Cheesman Edward H.
Harris Thomas D.
Rajopadhye Milind
Bristol-Myers Squibb Pharma Company
Gowling Lafleur Henderson Llp
LandOfFree
Vitronectin receptor antagonist pharmaceuticals for use in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vitronectin receptor antagonist pharmaceuticals for use in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vitronectin receptor antagonist pharmaceuticals for use in... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1644305